RSS Feeds
Search

Companies

Companies

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Brentuximab Vedotin – First Treatment Option for Relapsed Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (Subset of Non-Hodgkin Lymphoma)
May 2011 - 5 pages - $500
Cutaneous T-Cell Lymphoma - Pipeline Review, Q4 2010
Dec 2010 - 47 pages - $500
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Innovations in the Delivery of Cancer Therapies
Jan 2011 - 231 pages - $3,835
Drug Delivery: Global Industry Guide
Dec 2006 - 90 pages - $995
Cutaneous T-Cell Lymphoma - Pipeline Review, Q2 2011
Apr 2011 - 92 pages - $500
Follicular Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 213 pages - $500
Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 672 pages - $500
Drug Delivery Devices Market Outlook in Italy to 2016 - Inhalation Systems, Infusion Systems and Others
Aug 2010 - 85 pages - $2,500
Mantle Cell Lymphoma - Pipeline Review, Q3 2011
Jul 2011 - 268 pages - $500
More Related Market Research Reports >>>

Your selection

Industry sector
Drug delivery del
Nasal topical del
Suspension del
Therapeutic target
Oncology del
Lymphoma del
Geographic location
Europe del
Italy del

Browse By

Therapeutic target
Hodgkin's lymphoma
Lymphoma, AIDS-related
Neoplastic disease
Non-Hodgkins lymphoma

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us